Characteristics of COVID-19 Disease in Renal Transplant RecipientsArticle Published on 2024-01-242024-09-05 Journal: Medicina [Category] update2024, [키워드] Charlson Comorbidity Index Kidney transplantation Mortality SARS-CoV-2 [DOI] 10.3390/medicina60020201 PMC 바로가기 [Article Type] Article
The Influence of Comorbidities, General Health Status, and Self-Care Self-Efficacy on COVID-19 Symptoms During the Omicron WavePublic Health Published on 2023-11-212024-09-05 Journal: Cureus [Category] update2024, [키워드] adults with covid-19 Charlson Comorbidity Index covid-19 outpatient care covid-19 symptom rating scale depression and covid-19 mental health and covid-19 omicron self-care self-efficacy scale SF-12 the covid-19 symptoms severity [DOI] 10.7759/cureus.49176 PMC 바로가기 [Article Type] Public Health
Comorbidities and COVID-19 hospitalization, ICU admission and hospital mortality in Austria : A retrospective cohort studyArticle Published on 2022-12-012023-07-09 Journal: Wiener Klinische Wochenschrift [Category] COVID19(2023년), [키워드] Charlson Comorbidity Index Epidemiology Risk factors sex differences Underlying conditions. [DOI] 10.1007/s00508-022-02036-9 PMC 바로가기
Sex differences in determinants of COVID-19 severe outcomes – findings from the National COVID Cohort Collaborative (N3C)Article Published on 2022-10-122022-11-15 Journal: BMC Infectious Diseases [Category] 바이오마커, [키워드] absolute lymphocyte absolute neutrophil adjusted adjusted odds ratio Admission age Analysis association averaged Biomarker Biomarkers both sexes CCI Charlson Comorbidity Index comorbid condition Comorbidities Comorbidity components COVID COVID-19 COVID-19 severity CRP death death rate defined determinant disease Elevation examined ferritin Health highlight hospital Hospitalized IMV Inflammation inflammatory biomarkers Invasive mechanical ventilation lab value Liver disease Logistic regression LOS lymphocytopenia magnitude male medication men men and women moderate to severe Mortality Myocardial infarction N-terminal neutrophil outcome Patient peptide Platelet Platelets predictor previous study Primary outcome procalcitonin Protein remained renal Research retrospective cohort risk risk factor risk of death secondary outcome Sex Sex difference sex differences significantly solid tumor with COVID-19 women [DOI] 10.1186/s12879-022-07776-7 PMC 바로가기
Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational studyArticle Published on 2022-10-082022-11-15 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Abstract Admission age ambulatory patient Analysis Antiviral antiviral drug authority B.1.1.529 Case-control Charlson Comorbidity Index China Chinese clinical effectiveness Cohort Community Control COVID-19 outpatient Cox regression death Diagnosis diagnosis of SARS-CoV-2 Disease progression dominant Effectiveness glomerular filtration rate hazard Hong Kong hospitalisation HRs identify in both group In-hospital In-hospital death Infection intensive care Invasive mechanical ventilation less Logistic regression lower risk material median molnupiravir Mortality Nirmatrelvir non-hospitalised Odds ratio Older older patients outcome Outpatient Patient patients with COVID-19 primary analysis reduced risk Region Registered retrospective cohort risk Ritonavir SARS-CoV-2 SARS-COV-2 infection sensitivity analysis Sex supported the SARS-CoV-2 translation used data vaccination variant [DOI] 10.1016/S0140-6736(22)01586-0 PMC 바로가기
Outcome of COVID-19 in Kidney Transplant Recipients Through the SARS-CoV-2 Variants Eras: Role of Anti-SARS-CoV-2 Monoclonal AntibodiesArticle Published on 2022-10-042022-11-15 Journal: Transplant International [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Administered Charlson Comorbidity Index complications COVID-19 COVID-19-related symptom death Diagnosis dose early administration early treatment Epidemiology Hospitalization incidence increased risk Infection kidney Kidney transplantation mAb mAbs monoclonal monoclonal antibodies monoclonal antibody Multivariate analysis Omicron variant onset of symptoms outcome Patient primary endpoint Primary outcome recipient role SARS-CoV-2 SARS-COV-2 infection significant decrease study period the SARS-CoV-2 Transplant vaccination [DOI] 10.3389/ti.2022.10721 PMC 바로가기
Early outcomes of lung resections in non-small cell lung cancer after COVID-19 pneumoniaResearch article Published on 2022-08-012022-10-05 Journal: Asian journal of surgery [Category] 치료기술, [키워드] age anatomical CCI Cell Charlson Comorbidity Index Comorbidity complications COVID-19 COVID-19 group evaluated expiratory female Gender Lobectomy LOS lung lung cancer lung resection Lymph node male material morbidity and mortality non-COVID-19 group objective outcome Patient patients performed Pneumonia postoperative Result significant difference single center statistically significant difference Thoracic Surgery two group Volume were recorded [DOI] 10.1016/j.asjsur.2022.04.080 [Article Type] Research article
Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases만성 폐질환 환자에서 BNT162b2 COVID-19 백신 2회 접종 후 손상된 면역학적 결과와 관련된 항체 반응 및 위험 인자Article Published on 2022-07-012022-09-12 Journal: BMJ Open Respiratory Research [Category] MERS, 진단, [키워드] 1:1 1.26 95% CI adjusted antibody concentration Antibody Response aRR association Asthma bronchiectasis Charlson Comorbidity Index chronic pulmonary disease cohort study Comorbidity Control controls copd epidemiology COVID-19 COVID-19 vaccination COVID-19 vaccine defined dose Factor fibrosis first vaccination functional geometric healthcare personnel Humoral response identify immunological immunological responses Immunosuppression immunosuppressive Inclusion increasing age Interaction interstitial Interstitial Fibrosis lowest mRNA neutralising neutralising antibody of BNT162b2 outcome Patient Poisson regression Prednisolone Primary outcome Prospective quartile Receptor binding domain reported Responder response responses risk risk factor secondary outcome tested vaccination [DOI] 10.1136/bmjresp-2022-001268 PMC 바로가기 [Article Type] Article
Predictors of Noninvasive Respiratory Support Failure in COVID-19 Patients: A Prospective Observational StudyObservational Study Published on 2022-06-062022-10-04 Journal: Medicina [Category] COVID19(2023년), SARS, 임상, [키워드] Acute hypoxemic respiratory failure AHRF approach AUC benefit can be used CCI Charlson Comorbidity Index COVID-19 cut-off value Efficacy exhibited Factor failure ferritin HFNC High-flow nasal cannula hypoxemic individual Intubated Invasive mechanical ventilation Logistic regression Lymphocyte count marker material Mortality nasal NIV Non-invasive non-invasive ventilation Odds ratio outcome Oxygenation Patient patients Predictive predictive factor predictor Prevalence Prospective required Research respiratory Respiratory failure respiratory rate ROX ROX index sensitivity serum ferritin level specificity subjects Treatment was used were used [DOI] 10.3390/medicina58060769 PMC 바로가기 [Article Type] Observational Study
Validation of a simplified comorbidity evaluation predicting clinical outcomes among patients with coronavirus disease 2019 – A multicenter retrospective observation studyObservational Study Published on 2022-06-012022-10-04 Journal: The American journal of emergency medicine [Category] COVID19(2023년), SARS, 임상, [키워드] Accuracy addition Admissions CCI changed Charlson Comorbidity Index chronic condition clinical Clinical outcome clinical outcomes Comorbidity coronavirus disease COVID COVID-19 COVID-19 outbreak COVID-19 pandemic COVID-19 patient COVID-19 severity Department Emergency enrolled hospital in-hospital mortality independent risk factor intensive care invasive mechanical logistic regressions multicenter observation Outbreaks Pandemic outbreaks. Patient percentage performed positive predict receiving retrospective risk SARS-CoV-2 PCR test tested three group validation was used [DOI] 10.1016/j.ajem.2022.03.011 PMC 바로가기 [Article Type] Observational Study